Author: Peter Mansell

The government will invest £102 million in National Health Service infrastructure for 19 dedicated Clinical Research Facilities (CRFs) for Experimental Medicine across England between 1 September 2012 and 31 March 2017.

Pierrel, the company based in Italy that provides contract research, manufacturing and other services to the pharmaceutical and life science industries worldwide, is in exclusive negotiations with mondoBIOTECH for a deal that would involve the financially troubled Swiss drug-discovery company merging with Pierrel’s contact research division, Pierrel Research.

Eli Lilly has launched the first two programmes in a global innovation initiative that aims to leverage mutually beneficial collaborations between the company and academia towards discovering and developing new medicines in areas of particular unmet need.

Australian contract research organisation (CRO) CPR Pharma Services has opened what it says is the first Good Laboratory Practice (GLP)-standard bioanalytical laboratory in Singapore.

Bristol-Myers Squibb (BMS) has formed a “strategic relationship” with Duke University’s Duke Translational Medicine Institute (DTMI) in the US that builds on a decade of collaboration in the fields of cardiology, endocrinology, and oncology.